Prakash (Pra…Cash) Gudsoorkar (Good..Soor..Kar)
@gudnephron
Followers
2K
Following
5K
Statuses
4K
Kidneydoc | @UCKidney | Lead, OncoNeph Program @UC_Health I Editorial Board @KidneyNews @akdhjounal
Mumbai➡️Toronto➡️Cincinnati
Joined December 2014
Great team effort Onconephrology issue 1 @ackdonline @NKF_NephPros @nkf 12 articles - 36 ✍️ 12 VAs led by @Nephro_Sparks @brian_rifkin @nephromythri + 9 VA team members #nephrtwitter #AcademicTwitter #onconephrology @onconephsociety
@CharuThakar @kdjhaveri @MegSise
6
17
93
@rc_oncneph @ShrutiGkidney @MayoClinicNeph @pittkidneyctr @DanaFarber @harvardmed congrats buddy well deserved
0
0
1
@edgarvlermamd @ISNkidneycare That’s a great news Edgar. You portray an apt representation of North America to @ISNkidneycare congrats
0
0
1
0
0
2
RT @NEJM: Hemophagocytic lymphohistiocytosis (HLH) is a severe and life-threatening syndrome characterized by overwhelming inflammation tha…
0
129
0
RT @HyperAHA: REVIEW: Transforming Hypertension Diagnosis and Management in The Era of Artificial Intelligence: A 2023 National Heart, Lung…
0
7
0
RT @VincentRK: MGUS: With increased testing and with mass spectrometry to detect monoclonal (M) proteins, we are increasingly finding small…
0
87
0
RT @adequator_app: ¡New calculator ! 🚨 Therapeutic Plasma Exchange (TPE) -Estimated plasma volume -Macromolecule Kinetics -Albumin rep…
0
26
0
@PaulHannaMD @KidneyNews @kdjhaveri @kantsmd @ShainaLange Congrats Paul and Rasha one of the best special issues in @KidneyNews
0
0
2
RT @MPerazella: Kidney360 had a great year! I want to point out the outstanding work of Drs. Aklilu and Shirali on the Update on Onco-Nephr…
0
5
0
RT @AiContentRebel: The Notes app is one of Apple's most powerful tools. But 85% of users only use it at a basic level. Here are 10 amazi…
0
828
0
RT @VincentRK: Myeloma Treatment Check this out. It is by far the best tool to tell you what options are available for patients based on t…
0
30
0
0
0
1
Looking forward to my friend and peads onconeph partner in crime @CincyChildrens presenting a talk on a very important topic on transition of care peads ⏩ adult @UCKidney
@UCincyMedicine
@uofcincy
@onconephsociety
American Society of OncoNephrology educational series presents “Bridging the Gap: Transitioning OncoNephrology Patients from Pediatric to Adult Care” By Dr. Stefanie W Benoit and moderated by @gudnephron When: This Friday, Dec 13, 12 PM EST Stay Tuned ….
0
0
4
RT @VincentRK: Just out: Paradigm changing AQUILA randomized trial in high risk smoldering myeloma #ASH24
@thanosdimop @NEJM Daratumumab…
0
127
0
0
0
2
RT @VincentRK: My Annual Updated Myeloma Treatment Algorithms thread. Bookmark! #ASH24
#ASH24VR 1. Newly diagnosed transplant ineligible.…
0
124
0
RT @KIReports: Addition of a #LoopDiuretic to #Norepinephrine During Treatment of #Hepatorenal Syndrome Type 1 #VisualAbstract by @priti89…
0
13
0
Thank you for this opportunity and spot light. It a true pleasure to work along side @kdjhaveri @kantsmd @ShainaLange
@ASNKidney
@KidneyNews
@UCKidney
@UCincyMedicine
ASN Kidney News Deputy Editor Spotlight: Prakash S. Gudsoorkar, MD, FASN, FNKF As Deputy Editor of Kidney News, Dr. Gudsoorkar contributes to the magazine’s overall strategy and editorial planning, with a focus on inviting key scientific and medical commentary across the spectrum of kidney care. Working closely with authors, he helps ensure that articles are accurate, comprehensive, and relevant for all readers. He frequently serves as an author, writing important commentary on topics such as onconephrology and policy. Gudsoorkar is assistant professor in the department of medicine and medical director of onconephrology service at University of Cincinnati Heath, OH. @gudnephron @UCKidney
0
2
14
RT @BeheraVineet: Are you using Semaglutide? Check how much you know about Semaglutide? Take our Semaglutide Quiz #KidneyKolumns @KidneyKo…
0
17
0